Avrobio Inc reported 10.16M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Akebia Therapeutics AKBA:US $ 44.33M 498K
Alnylam Pharmaceuticals ALNY:US $ 154.47M 31.91M
Applied Genetic Technologies AGTC:US $ 4.32M 494K
Epizyme EPZM:US $ 27.2M 3.66M
Gilead Sciences GILD:US $ 1.08B 567M
Intercept Pharmaceuticals ICPT:US $ 50.01M 10.58M
Karyopharm Therapeutics KPTI:US $ 38.77M 4.21M
Macrogenics MGNX:US $ 16.25M 670K
Sangamo Biosciences SGMO:US $ 14.91M 1.18M
Sarepta Therapeutics SRPT:US $ 71.84M 6.22M
Takeda 4502:JP 223.43B 7.65B